Braine l'Alleud, Belgium

Laurent Jacques Emile Calmus

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Janssen Sciences Ireland Unlimited Company. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurent Jacques Emile Calmus. Retrieved from https://idiyas.com/inventor/laurent-jacques-emile-calmus

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Laurent Jacques Emile Calmus

Introduction

Laurent Jacques Emile Calmus is a notable inventor based in Braine l'Alleud, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for viral infections.

Latest Patents

Calmus holds one patent titled "Pyrimidine prodrugs for the treatment of viral infections and further diseases." This invention relates to pyrimidine prodrug derivatives, processes for their preparation, pharmaceutical compositions, and their use in therapy. His work in this area showcases his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Calmus is currently associated with Janssen Sciences Ireland Unlimited Company, where he continues to innovate and contribute to the pharmaceutical industry. His expertise in drug development has positioned him as a valuable asset in his field.

Collaborations

Calmus has collaborated with notable colleagues such as Jérôme Émile Georges Guillemont and Tim Hugo Maria Jonckers. These partnerships have likely enhanced the scope and impact of his research and inventions.

Conclusion

Laurent Jacques Emile Calmus exemplifies the spirit of innovation in the pharmaceutical industry through his patent and collaborative efforts. His work continues to pave the way for advancements in the treatment of viral infections and other diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…